Pricing Log in Create free account

Faeth Therapeutics, Inc. (FTH) vs VectivBio Holding AG (VECT)

Faeth Therapeutics, Inc. and VectivBio Holding AG are both Biotechnology companies. Faeth Therapeutics, Inc. and VectivBio Holding AG are of similar size ($545.5M and $532.3M). Across the 9 metrics below, VectivBio Holding AG leads on 5 and Faeth Therapeutics, Inc. on 4.

Valuation

Metric FTH VECT Biotechnology median
P/E n/m n/m 8.50
P/S n/m n/m 9.71
P/B 0.61 3.94 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.32 n/m 0.64
EV/Sales n/m n/m 9.21
Earnings yield (753.86%) (27.42%) (33.15%)
Free cash flow yield (31.94%) (21.00%) (25.50%)

Profitability

Metric FTH VECT Biotechnology median
Gross margin 0.00% — 65.16%
Operating margin 0.00% — 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (195.26%) (147.18%) (56.36%)
Return on assets (176.88%) (111.86%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric FTH VECT Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 30.33% 34.37% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric FTH VECT Biotechnology median
Debt to equity 0.00 0.05 0.00
Current ratio 19.69 9.14 4.72
Net debt to EBITDA 0.96 2.63 0.96

Dividend

Metric FTH VECT Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric FTH VECT Biotechnology median
Market cap 532.31m 545.50m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack